Back to Authors

Elsekaily, Omar

Mayo Clinic

Mayo Clinic

Citations 4

Clinician Perspectives on Clinical Decision Support for Familial Hypercholesterolemia
Bangash, Hana , Elsekaily, Omar, Saadatagah, Seyedmohammad , Sutton, Joseph , Johnsen, Paul J., Gundelach, Justin H. , Kamzabek, Arailym, Johnsen, Paul, Freimuth, Robert, Freimuth, Robert R. , Caraballo, Pedro J. , Kullo, Iftikhar J.

Journal of Personalized Medicine | May 31, 2023 | Volume: 13 | Issue: 6 | Pages: 929

10.3390/jpm13060929 Get It

Familial Hypercholesterolemia (FH) is underdiagnosed in the United States. Clinical decision support (CDS) could increase FH detection once implemented in clinical workflows. We deployed CDS for FH at an academic medical center and sought clinician insights using an implementation survey. In November 2020, the FH CDS was deployed in the electronic health record at all Mayo Clinic sites in two formats: a best practice advisory (BPA) and an in-basket alert. Over three months, 104 clinicians participated in the survey (response rate 11.1%). Most clinicians (81%) agreed that CDS implementation was a good option for identifying FH patients; 78% recognized the importance of implementing the tool in practice, and 72% agreed it would improve early diagnosis of FH. In comparing the two alert formats, clinicians found the in-basket alert more acceptable (p = 0.036) and more feasible (p = 0.042) than the BPA. Overall, clinicians favored implementing the FH CDS in clinical practice and provided feedback that led to iterative refinement of the tool. Such a tool can potentially increase FH detection and optimize patient management.
Effect of TAVR Approach and Other Baseline Factors on the Incidence of Acute Kidney Injury: A Systematic Review and Meta-Analysis
Alzu’bi, Hossam , Rmilah, Anan Abu , Haq, Ikram-UI, Al‐Abdouh, Ahmad , Elsekaily, Omar, Jaber, Suhaib, Qaisi, Ibraheem, Yagmour, Asil , Dajani, Hamada, Ahmed, Azza , elhag, Ahmed, Deshmukh, Abhishek , Al-Abdouh, Ahmad , Hasan, Bashar , Kheiri, Babikir , Hasan, Bashar , Kashani, Kianoush

Journal of Interventional Cardiology | October 28, 2022 | Volume: 2022 | Issue: No issue available | Pages: 1-9

10.1155/2022/3380605 Get It

Background. Acute kidney injury (AKI) is a well-known complication following a transcatheter aortic valve replacement (TAVR) and is associated with higher morbidity and mortality. Objective. We aim to compare the risk of developing AKI after transfemoral (TF), transapical (TA), and transaortic (TAo) approaches following TAVR. Methods. We searched Medline and EMBASE databases from January 2009 to January 2021. We included studies that evaluated the risk of AKI based on different TAVR approaches. After extracting each study’s data, we calculated the risk ratio and 95% confidence intervals using RevMan software 5.4. Publication bias was assessed by the forest plot. Results. Thirty-six (36) studies, consisting of 70,406 patients undergoing TAVR were included. Thirty-five studies compared TF to TA, and only seven investigations compared TF to TAo. AKI was documented in 4,857 out of 50,395 (9.6%) patients that underwent TF TAVR compared to 3,155 out of 19,721 (16%) patients who underwent TA-TAVR, with a risk ratio of 0.49 (95% CI, 0.36–0.66; p < 0.00001 ). Likewise, 273 patients developed AKI out of the 1,840 patients (14.8%) that underwent TF-TAVR in contrast to 67 patients out of the 421 patients (15.9%) that underwent TAo-TAVR, with a risk ratio of 0.51 (95% CI, 0.27–0.98; p = 0.04). There was no significant risk when we compared TA to TAo approaches, with a risk ratio of 0.89 (95% CI, 0.29–2.75; p = 0.84). Conclusion. The risk of post-TAVR AKI is significantly lower in patients who underwent TF-TAVR than those who underwent TA-TAVR or TAo-TAVR.
Abstract P179: A Text Processing Tool To Identify And Characterize Carotid Artery Stenosis In Radiology Reports
Elsekaily, Omar, Alhalabi, Lubna, Kullo, Iftikhar, Saadatagah, Seyedmohammad

Arteriosclerosis, Thrombosis, and Vascular Biology | May 2, 2022 | Volume: 41 | Issue: Suppl_1 | Pages: No page available

10.1161/atvb.41.suppl_1.p179 Get It

Introduction: We aimed to identify and characterize carotid artery stenosis (CAS), defined as ≥40% stenosis in the internal carotid artery (ICA) or the common carotid artery (CCA), among participants of the Mayo Vascular Disease Biorepository (VDB, n = 11,814). Hypothesis: A string-based text processing (TP) tool coded in R can analyze radiology text reports to ascertain and characterize CAS. Methods: After importing a radiology report into R, it was segmented for analysis and each segment was tested for 22 unique features. The TP tool was able to i) identify stenosis in the ICA or the CCA while excluding stenosis of vertebral arteries, subclavian arteries, or external carotid arteries, ii) recognize both quantitative and qualitative descriptions of CAS, iii) interpret numerical expressions by considering the surrounding text, iv) detect negations, and v) ascertain previous revascularization procedures if mentioned in the text. We manually ascertained CAS and characterized it in 800 randomly selected radiology reports to assess the performance of the TP tool in terms of precision, recall, and F-score. Results: We retrieved 21,651 imaging reports for 6,342 unique patients including 20,461 ultrasonography reports, 812 magnetic resonance imaging reports, 357 computed tomography scan reports, and 21interventional radiology reports. The performance of TP is outlined in Table 1 . Conclusion: We demonstrate that a string-based TP tool coded in R is efficient and accurate in identifying and characterizing CAS from carotid radiology reports. The tool does not require natural language processing and could be used in a wide range of settings for genetic and biomarker studies.
Deploying Clinical Decision Support for Familial Hypercholesterolemia
Bangash, Hana , Sutton, Joseph , Gundelach, Justin H. , Pencille, Laurie J., Makkawy, Ahmed , Elsekaily, Omar, Mir, Ali Mohammadpour, Pencille, Laurie, Mir, Ali, Freimuth, Robert, Dikilitas, Ozan , Freimuth, Robert R. , Caraballo, Pedro J. , Kullo, Iftikhar J.

ACI Open | January 1, 2021 | Volume: 04 | Issue: 02 | Pages: e157-e161

10.1055/s-0040-1721489 Get It

AbstractObjective Familial hypercholesterolemia (FH), a prevalent genomic disorder that increases risk of coronary heart disease, remains significantly underdiagnosed. Clinical decision support (CDS) tools have the potential to increase FH detection. We describe our experience in the development and implementation of a genomic CDS for FH at a large academic medical center.Methods CDS development and implementation were conducted in four phases: (1) development and validation of an algorithm to identify “possible FH”; (2) obtaining approvals from institutional committees to develop the CDS; (3) development of the initial prototype; and (4) use of an implementation science framework to evaluate the CDS.Results The timeline for this work was approximately 4 years; algorithm development and validation occurred from August 2018 to February 2020. During this 4-year period, we engaged with 15 stakeholder groups to build and integrate the CDS, including health care providers who gave feedback at each stage of development. During CDS implementation six main challenges were identified: (1) need for multiple institutional committee approvals; (2) need to align the CDS with institutional knowledge resources; (3) need to adapt the CDS to differing workflows; (4) lack of institutional guidelines for CDS implementation; (5) transition to a new institutional electronic health record (EHR) system; and (6) limitations of the EHR related to genomic medicine.Conclusion We identified multiple challenges in different domains while developing CDS for FH and integrating it with the EHR. The lessons learned herein may be helpful in streamlining the development and deployment of CDS to facilitate genomic medicine implementation.